The exercise price for warrants of series TO 7 in Smoltek has been determined to SEK 3.56 and the exercise period starts, June 5, 2023
This press release is an English version of the previously published Swedish version, which has interpretive precedence.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, BELARUS, JAPAN, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE, CANADA OR ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE FURTHER ACTION THAN WHAT IS REQUIRED UNDER SWEDISH LAW.
Smoltek Nanotech Holding AB (publ) ("Smoltek" or the "Company") issued warrants of series TO 7 in connection with the Company's rights issue of units in November 2022. Each warrant of series TO 7 entitles the holder to subscribe for one (1) new share in the Company ("Warrant"). The exercise price for the Warrants to subscribe for new shares in the Company is set at 70 percent of the volume-weighted average price of the Company's shares on the Spotlight Stock Market during the period from May 17, 2023, to May 31, 2023, but not less than the share's quota value (approximately SEK 0.12) and not higher than SEK 13.50. The volume-weighted average price of the Company's shares during the measurement period was approximately SEK 5.10, therefore, the exercise price of Warrants has been set at SEK 3.56. The exercise period for the Warrants runs from June 5, 2023, up to and including June 19, 2023.
The complete terms and conditions for the Warrants are available on the Company's website: www.smoltek.com/investors
Summarized terms for the Warrants of series TO 7
Exercise period: June 5, 2023 – June 19, 2023
Exercise price: SEK 3.56 per share
Issue size: 2,452,996 Warrants entitle the holder to subscribe for 2,452,996 new shares. Upon full exercise, the Company will receive approximately SEK 8.7 million, before issuance costs.
Last day for trading Warrants of series TO 7: June 15, 2023
Share capital, shares and dilution
Upon full exercise of all Warrants, the share capital will increase by SEK 292,221.13, from SEK 1,690,297.31 to SEK 1,982,518.44, and the number of shares will increase by 2,452,996 shares, from 14,188,887 shares to 16,641,883 shares. The dilution upon full exercise of all Warrants amounts to approximately 14.74 percent of the total number of shares and votes in the Company.
Please note that Warrants that are not exercised by June 19, 2023, or sold by June 15, 2023, will expire worthless. In order to prevent the Warrants from expiring worthless, they need to be actively exercised for subscription of new shares in the Company or sold. Please be aware that some custodians may close the subscription opportunity earlier than June 19, 2023. Holders of Warrants through custodians are therefore advised to contact their custodian early during the exercise period to obtain information on subscription and payment.
Advisers
Mangold Fondkommission AB is financial adviser and MAQS Advokatbyrå AB is legal adviser for the Company in connection with the subscription of the Warrant.
For further information
Håkan Persson, CEO of Smoltek Nanotech Holding AB
E-mail: hakan.persson@smoltek.com
Phone: +46 731 03 05
Website: www.smoltek.com/investors
About Smoltek
Smoltek is a Swedish technology company based in Gothenburg, specialized in the development and integration of carbon nanotechnology. The technology is used in the manufacture of vertical carbon nanostructures to create a three-dimensional surface in precision-defined patterns to solve advanced materials engineering problems in the process and semiconductor industry. Today, we focus on capturing the potential of the digital mobile phone revolution and the development of green energy production, which has resulted in the Company's two different business areas: semiconductors and hydrogen. In the semiconductor business area, the Company obtains ultra-thin capacitors intended for decoupling capacitors for application processes in mobile phones, and in the hydrogen business area, the first product is planned to be a highly efficient cell material intended for use in PEM electrolysers to drastically reduce investment cost to produce fossil-free hydrogen. Smoltek's technology makes components and materials thinner, more energy efficient, more powerful, and cheaper. This is made possible by the three-dimensional surface structure of the carbon nanostructures, which creates a surface that can be refined multiple times in the same volume for, for example, electrical and chemical processes. Smoltek has a strongly patent-protected technology consisting of roughly 110 patent assets within 20 patent families, of which 78 are currently granted patents. The company's stock is listed on the Spotlight Stock Market. For more information, go to www.smoltek.com/investors.
Important information
Publication, disclosure, or distribution of this press release may in certain jurisdictions be subject to restrictions by law, and persons in jurisdictions where this press release has been published or distributed should inform themselves about and comply with such legal restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with applicable rules in their respective jurisdiction. This press release does not constitute an offer to acquire or subscribe for any securities in Smoltek in any jurisdiction, neither from Smoltek nor from any other party.
This press release does not constitute an offer or invitation to acquire or subscribe for securities in the United States. The securities mentioned herein may not be sold in the United States without registration or without the application of an exemption from registration under the U.S. Securities Act of 1933 ("Securities Act"), and may not be offered or sold in the United States unless they are registered, exempt from, or in a transaction not subject to the registration requirements under the Securities Act. There is no intention to register any securities mentioned herein in the United States or to make a public offer regarding such securities in the United States. The information in this press release may not be disclosed, published, copied, reproduced, or distributed, directly or indirectly, in whole or in part, in or into Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, South Africa, the United States, Belarus, Russia, or any other jurisdiction where such disclosure, publication, or distribution of this information would contravene applicable regulations or where such action is subject to legal restrictions or would require additional registration or other measures beyond what is required under Swedish law. Actions in violation of this instruction may constitute a breach of applicable securities laws.